161 related articles for article (PubMed ID: 10463285)
1. Pathological evaluation of renal tumors in children: international society of pediatric oncology approach.
Boccon-Gibod LA
Pediatr Dev Pathol; 1998; 1(3):243-8. PubMed ID: 10463285
[TBL] [Abstract][Full Text] [Related]
2. Anaplasia in Wilms tumor: A critical review.
Vujanić GM; Mifsud W
Pediatr Blood Cancer; 2024 Jul; 71(7):e31000. PubMed ID: 38605554
[TBL] [Abstract][Full Text] [Related]
3. Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity.
Weirich A; Ludwig R; Graf N; Abel U; Leuschner I; Vujanic GM; Mehls O; Boos J; Beck J; Royer-Pokora B; Voûte PA
Ann Oncol; 2004 May; 15(5):808-20. PubMed ID: 15111352
[TBL] [Abstract][Full Text] [Related]
4. New definitions of focal and diffuse anaplasia in Wilms tumor: the International Society of Paediatric Oncology (SIOP) experience.
Vujanić GM; Harms D; Sandstedt B; Weirich A; de Kraker J; Delemarre JF
Med Pediatr Oncol; 1999 May; 32(5):317-23. PubMed ID: 10219330
[TBL] [Abstract][Full Text] [Related]
5. Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood.
Vujanić GM; Sandstedt B; Harms D; Kelsey A; Leuschner I; de Kraker J;
Med Pediatr Oncol; 2002 Feb; 38(2):79-82. PubMed ID: 11813170
[TBL] [Abstract][Full Text] [Related]
6. Botryoid Wilms tumor: a non-existent "entity" causing diagnostic and staging difficulties.
Vujanić GM; Schiavo Lena M; Sebire NJ
Virchows Arch; 2019 Feb; 474(2):227-234. PubMed ID: 30515564
[TBL] [Abstract][Full Text] [Related]
7. Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour.
Taran K; Sitkiewicz A; Andrzejewska E; Kobos J
Pol J Pathol; 2011; 62(2):84-8. PubMed ID: 21866463
[TBL] [Abstract][Full Text] [Related]
8. Preoperative care of infants with nephroblastoma. The International Society of Pediatric Oncology 6 experience.
Coppes MJ; Tournade MF; Lemerle J; Weitzman S; Rey A; Burger D; Carli M; Voûte PA
Cancer; 1992 Jun; 69(11):2721-5. PubMed ID: 1315208
[TBL] [Abstract][Full Text] [Related]
9. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and outcomes of preoperatively treated patients with anaplastic Wilms tumors registered in the UK SIOP-WT-2001 and IMPORT study cohorts (2002-2020).
Vujanić GM; Mifsud W; Chowdhury T; Al-Saadi R; Pritchard-Jones K;
Cancer; 2022 Apr; 128(8):1666-1675. PubMed ID: 35119702
[TBL] [Abstract][Full Text] [Related]
11. National Wilms Tumor Study: an update for pathologists.
Beckwith JB
Pediatr Dev Pathol; 1998; 1(1):79-84. PubMed ID: 10463275
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of blastemal predominant histology in initially resected Wilms' tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan.
Kinoshita Y; Suminoe A; Inada H; Yagi M; Yanai F; Zaizen Y; Nishi M; Inomata Y; Kawakami K; Matsufuji H; Suenobu S; Handa N; Kohashi K; Oda Y; Hara T; Taguchi T
J Pediatr Surg; 2012 Dec; 47(12):2205-9. PubMed ID: 23217877
[TBL] [Abstract][Full Text] [Related]
13. Complete necrosis induced by preoperative chemotherapy in Wilms tumor as an indicator of low risk: report of the international society of paediatric oncology (SIOP) nephroblastoma trial and study 9.
Boccon-Gibod L; Rey A; Sandstedt B; Delemarre J; Harms D; Vujanic G; De Kraker J; Weirich A; Tournade MF
Med Pediatr Oncol; 2000 Mar; 34(3):183-90. PubMed ID: 10696124
[TBL] [Abstract][Full Text] [Related]
14. Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol.
van den Heuvel-Eibrink MM; Hol JA; Pritchard-Jones K; van Tinteren H; Furtwängler R; Verschuur AC; Vujanic GM; Leuschner I; Brok J; Rübe C; Smets AM; Janssens GO; Godzinski J; Ramírez-Villar GL; de Camargo B; Segers H; Collini P; Gessler M; Bergeron C; Spreafico F; Graf N;
Nat Rev Urol; 2017 Dec; 14(12):743-752. PubMed ID: 29089605
[TBL] [Abstract][Full Text] [Related]
15. Pathology of Wilms' tumour in International Society of Paediatric Oncology (SIOP) and Children's oncology group (COG) renal tumour studies: Similarities and differences.
Vujanić GM; Parsons LN; D'Hooghe E; Treece AL; Collini P; Perlman EJ
Histopathology; 2022 Jun; 80(7):1026-1037. PubMed ID: 35275409
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01.
Graf N; van Tinteren H; Bergeron C; Pein F; van den Heuvel-Eibrink MM; Sandstedt B; Schenk JP; Godzinski J; Oldenburger F; Furtwängler R; de Kraker J
Eur J Cancer; 2012 Nov; 48(17):3240-8. PubMed ID: 22795263
[TBL] [Abstract][Full Text] [Related]
17. From Wilms to kidney tumors: which ones require a biopsy?
Brisse HJ; de la Monneraye Y; Cardoen L; Schleiermacher G
Pediatr Radiol; 2020 Jul; 50(8):1049-1051. PubMed ID: 32248272
[TBL] [Abstract][Full Text] [Related]
18. [Wilms' tumor: current classification and the basic principles of a morphological study].
Muianich GM; Popov SD; Popova ED
Arkh Patol; 2006; 68(6):46-9. PubMed ID: 17290897
[TBL] [Abstract][Full Text] [Related]
19. Central pathology review in multicenter trials and studies: lessons from the nephroblastoma trials.
Vujanić GM; Sandstedt B; Kelsey A; Sebire NJ
Cancer; 2009 May; 115(9):1977-83. PubMed ID: 19241454
[TBL] [Abstract][Full Text] [Related]
20. The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol.
Vujanić GM; Gessler M; Ooms AHAG; Collini P; Coulomb-l'Hermine A; D'Hooghe E; de Krijger RR; Perotti D; Pritchard-Jones K; Vokuhl C; van den Heuvel-Eibrink MM; Graf N;
Nat Rev Urol; 2018 Nov; 15(11):693-701. PubMed ID: 30310143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
